Package 50090-5253-4

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50090-5253-4
Digits Only 5009052534
Product NDC 50090-5253
Product ID 50090-5253_caca7395-7eaa-4d05-bd4b-fb92e997f480
Description

30 TABLET in 1 BOTTLE (50090-5253-4)

Marketing

Marketing Status
Marketed Since 2020-10-14
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "caca7395-7eaa-4d05-bd4b-fb92e997f480", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897640"], "spl_set_id": ["5467dad4-f3ba-4036-b5f4-4d2d4d5abc34"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-5253-4)", "package_ndc": "50090-5253-4", "marketing_start_date": "20201014"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "50090-5253_caca7395-7eaa-4d05-bd4b-fb92e997f480", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "50090-5253", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20190515", "listing_expiration_date": "20261231"}